scott galloway glp 1 on GLP-1 Drugs (4 min) Scott Galloway drops a bold

A recent post hoc analysis of the SURPASS-1 through SURPASS-5 clinical trials further supports tirzepatide having a renal-protective action [96]

However, like most medications, GLP-1s come with potential side effects

A physical or electronic signature of a person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed

2023 Nov 16;9(1):7

Its frequency usually ranges between 15 and 50%, is higher during the first 45 weeks of treatment when gastric emptying is most delayed, and symptoms are usually moderate and disappear within about 8 days of onset

If prescribed, youll receive clear instructions and ongoing support from our care team